{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:58:51Z","timestamp":1790092731551,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001312","name":"University of Brighton","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.humimm.2025.111249","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T20:30:25Z","timestamp":1738960225000},"page":"111249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Convalescent COVID-19 monocytes exhibit altered steady-state gene expression and reduced TLR2, TLR4 and RIG-I induced cytokine expression"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1821-2859","authenticated-orcid":false,"given":"Sarah","family":"Unterberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8463-1739","authenticated-orcid":false,"given":"Nadia","family":"Terrazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1665-1142","authenticated-orcid":false,"given":"Sandra","family":"Sacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10223","key":"10.1016\/j.humimm.2025.111249_b0005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China. the Lancet"},{"issue":"18","key":"10.1016\/j.humimm.2025.111249_b0010","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.humimm.2025.111249_b0015","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"10453","key":"10.1016\/j.humimm.2025.111249_b0020","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","article-title":"Long COVID: a clinical update","volume":"404","author":"Greenhalgh","year":"2024","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.humimm.2025.111249_b0025","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s41590-023-01601-2","article-title":"SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)","volume":"24","author":"Proal","year":"2023","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2025.111249_b0030","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41556-021-00690-1","article-title":"Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19","volume":"23","author":"You","year":"2021","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.humimm.2025.111249_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091253","article-title":"Alterations in Circulating Monocytes Predict COVID-19 Severity and Include Chromatin Modifications Still Detectable Six Months after Recovery","volume":"9","author":"Utrero-Rico","year":"2021","journal-title":"Biomedicines"},{"issue":"18","key":"10.1016\/j.humimm.2025.111249_b0040","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1016\/j.cell.2023.07.019","article-title":"Epigenetic memory of coronavirus infection in innate immune cells and their progenitors","volume":"186","author":"Cheong","year":"2023","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.humimm.2025.111249_b0045","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150542","article-title":"SARS-CoV-2\u2013associated ssRNAs activate inflammation and immunity via TLR7\/8","volume":"6","author":"Salvi","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.humimm.2025.111249_b0050","doi-asserted-by":"crossref","first-page":"13638","DOI":"10.1038\/s41598-021-92940-3","article-title":"The RNA sensor MDA5 detects SARS-CoV-2 infection","volume":"11","author":"Sampaio","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2025.111249_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.700926","article-title":"RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses","volume":"12","author":"Kouwaki","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2025.111249_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/v14050999","article-title":"SARS-CoV-2 Envelope (E) Protein Binds and Activates TLR2 Pathway: A Novel Molecular Target for COVID-19 Interventions","volume":"14","author":"Plan\u00e8s","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.humimm.2025.111249_b0065","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","article-title":"TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines","volume":"22","author":"Zheng","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2025.111249_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06187","article-title":"SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages","volume":"7","author":"Shirato","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.humimm.2025.111249_b0075","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41422-021-00501-0","article-title":"Publisher Correction: SARS-CoV-2 spike protein interacts with and activates TLR4","volume":"31","author":"Zhao","year":"2020","journal-title":"Cell Res."},{"issue":"51","key":"10.1016\/j.humimm.2025.111249_b0080","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd6197","article-title":"Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19","volume":"5","author":"Mann","year":"2020","journal-title":"Sci. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2025.111249_b0085","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/nsr\/nwaa041","article-title":"Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl. Sci. Rev."},{"issue":"2","key":"10.1016\/j.humimm.2025.111249_b0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0171-2985(11)80546-2","article-title":"Tolerance to Lipopolysaccharide in Human Blood Monocytes","volume":"193","author":"L\u00f6ms Ziegler-Heitbrock","year":"1995","journal-title":"Immunobiology"},{"issue":"12","key":"10.1016\/j.humimm.2025.111249_b0095","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.4049\/jimmunol.165.12.7096","article-title":"Synergy and Cross-Tolerance Between Toll-Like Receptor (TLR) 2- and TLR4-Mediated Signaling Pathways","volume":"165","author":"Sato","year":"2000","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2025.111249_b0100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"43","key":"10.1016\/j.humimm.2025.111249_b0105","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Gu\u00e9rin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.humimm.2025.111249_b0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1399-0039.1974.tb00252.x","article-title":"Separation of Blood Leucocytes, Granulocytes and Lymphocytes","volume":"4","author":"B\u00f8yum","year":"1974","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.humimm.2025.111249_b0115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2212\u0394\u0394CT Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.humimm.2025.111249_b0120","first-page":"W566","volume":"43","author":"Metsalu","year":"2015","journal-title":"ClustVis: a Web Tool for Visualizing Clustering of Multivariate Data Using Principal Component Analysis and Heatmap Rheumatology"},{"issue":"9","key":"10.1016\/j.humimm.2025.111249_b0125","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.it.2012.05.002","article-title":"Dissecting negative regulation of Toll-like receptor signaling","volume":"33","author":"Kondo","year":"2012","journal-title":"Trends Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2025.111249_b0130","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ni968","article-title":"SIGIRR, a negative regulator of Toll-like receptor\u2013interleukin 1 receptor signaling","volume":"4","author":"Wald","year":"2003","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.humimm.2025.111249_b0135","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/me.2005-0301","article-title":"Suppressor of Cytokine Signaling-3 Inhibits Interleukin-1 Signaling by Targeting the TRAF-6\/TAK1 Complex","volume":"20","author":"Frob\u00f8se","year":"2006","journal-title":"Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.humimm.2025.111249_b0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","article-title":"IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling","volume":"110","author":"Kobayashi","year":"2002","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.humimm.2025.111249_b0145","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1074\/jbc.M109537200","article-title":"Negative Regulation of Toll-like Receptor-mediated Signaling by Tollip *.","volume":"277","author":"Zhang","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.humimm.2025.111249_b0150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12026-013-8463-2","article-title":"A20-mediated negative regulation of canonical NF-\u03baB signaling pathway","volume":"57","author":"Pujari","year":"2013","journal-title":"Immunol. Res."},{"key":"10.1016\/j.humimm.2025.111249_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.04.005","article-title":"Cell Survival and Cytokine Release after Inflammasome Activation Is Regulated by the Toll-IL-1R Protein SARM","author":"Carty","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2025.111249_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1200789","article-title":"COVID-19 inactivated and non-replicating viral vector vaccines induce regulatory training phenotype in human monocytes under epigenetic control","volume":"13","author":"Antunes","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111249_b0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.humimm.2025.111249_b0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2025.111249_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.709759","article-title":"Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals","volume":"12","author":"Tserel","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111249_b0180","doi-asserted-by":"crossref","first-page":"20533","DOI":"10.1038\/s41598-020-77525-w","article-title":"Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19","volume":"10","author":"Haljasm\u00e4gi","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.humimm.2025.111249_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109975","article-title":"SARS-CoV-2 envelope protein regulates innate immune tolerance","volume":"27","author":"Geanes","year":"2024","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.humimm.2025.111249_b0190","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2025.111249_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1329026","article-title":"Reduced monocyte proportions and responsiveness in convalescent COVID-19 patients","volume":"14","author":"Ravkov","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111249_b0205","first-page":"49","article-title":"Differential roles of RIG-I like receptors in SARS-CoV-2 infection","volume":"8","author":"Yang","year":"2021","journal-title":"Mil. Med. Res."},{"issue":"1586","key":"10.1016\/j.humimm.2025.111249_b0210","article-title":"Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5","volume":"10","author":"Brisse","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111249_b0215","doi-asserted-by":"crossref","first-page":"13414","DOI":"10.1038\/srep13414","article-title":"STAT1 deficiency redirects IFN signalling toward suppression of TLR response through a feedback activation of STAT3","volume":"5","author":"Kim","year":"2015","journal-title":"Sci. Rep."},{"issue":"26","key":"10.1016\/j.humimm.2025.111249_b0220","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1182\/blood-2010-04-280586","article-title":"A novel form of human STAT1 deficiency impairing early but not late responses to interferons","volume":"116","author":"Kong","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2025.111249_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199157","article-title":"Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients","volume":"334","author":"Bernal","year":"2023","journal-title":"Virus Res."},{"issue":"6515","key":"10.1016\/j.humimm.2025.111249_b0230","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.humimm.2025.111249_b0235","first-page":"708","volume":"10","author":"Feng","year":"2021","journal-title":"Aging and Interferons: Impacts on Inflammation and Viral Disease Outcomes."},{"issue":"10","key":"10.1016\/j.humimm.2025.111249_b0240","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.1074\/jbc.M110.182873","article-title":"Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression","volume":"286","author":"Xiong","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.humimm.2025.111249_b0245","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1172\/JCI115493","article-title":"Dysregulation of in vitro cytokine production by monocytes during sepsis","volume":"88","author":"Munoz","year":"1991","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.humimm.2025.111249_b0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41421-020-0168-9","article-title":"Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing","volume":"6","author":"Wen","year":"2020","journal-title":"Cell Discovery"},{"issue":"26","key":"10.1016\/j.humimm.2025.111249_b0255","doi-asserted-by":"crossref","first-page":"25233","DOI":"10.1074\/jbc.M501363200","article-title":"SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms","volume":"280","author":"Qin","year":"2005","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.humimm.2025.111249_b0260","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.immuni.2023.03.005","volume":"56","author":"Gao","year":"2023","journal-title":"Immunity"},{"issue":"23","key":"10.1016\/j.humimm.2025.111249_b0265","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1016\/j.cell.2022.09.032","article-title":"Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses","volume":"185","author":"Buckner","year":"2022","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.humimm.2025.111249_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251170","article-title":"Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis","volume":"16","author":"Musuuza","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.humimm.2025.111249_b0275","doi-asserted-by":"crossref","first-page":"12703","DOI":"10.1038\/s41598-021-92220-0","article-title":"Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients","volume":"11","author":"Shafran","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2025.111249_b0280","article-title":"Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study","volume":"380","author":"Mizrahi","year":"2023","journal-title":"BMJ"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925000205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925000205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T17:58:43Z","timestamp":1742234323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885925000205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0198885925000205"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111249","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Convalescent COVID-19 monocytes exhibit altered steady-state gene expression and reduced TLR2, TLR4 and RIG-I induced cytokine expression","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}],"article-number":"111249"}}